Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8791 to 8805 of 9038 results

  1. Benefits of new Alzheimer's treatment lecanemab are too small to justify the cost to the NHS

    Our draft recommendation follows analysis of clinical trial evidence and reviewing the benefits of slowing disease progression, with the cost of treatment.

  2. First treatment to be recommended by NICE at the same time it is approved for advanced lymphoma in the UK

    More than 700 people set to benefit from new treatment option for advanced lymphoma.

  3. NICE recommends innovative technology for people with breast cancer

    A magnetic marker liquid injected into people with invasive breast cancer will help surgeons discover if the cancer has spread.

  4. First gene therapy for rare genetic neurodegenerative disorder in children, recommended in NICE draft guidance

    Children with a rare, fatal, genetic disorder will be able to benefit from a new one-off treatment under new NICE guidance.

  5. New LSE master's degree in Evaluation of Health Care Interventions and Outcomes

    NICE is collaborating with the London School of Economics and Political Science (LSE) to develop an executive master’s degree in health care decision-making.

  6. NICE has recommended a new option for people with difficult-to-treat multiple myeloma

    Around 5,700 cases of multiple myeloma are diagnosed each year in the UK. NICE has recommended a new option for people with difficult-to-treat multiple myeloma.

  7. NICE gets ready to assess new dementia treatments

    NICE’s methods and processes for evaluating new treatments for use in the NHS are appropriate for the new class of Alzheimer’s drugs but key issues need to be considered, a new report has found.

  8. Learn more about NICE's updated menopause guideline

    Home News Podcasts Learn more about NICE's updated menopause guideline Podcasts 29 November 2024 Listen About this episode Our guests are

  9. New “artificial pancreas” technology set to change the lives of over 100,000 people with type 1 diabetes

    Around 105,000 people with type 1 diabetes could benefit from NICE’s draft recommendation

  10. NICE welcomes Dr Michael Borowitz as new NICE non-executive director

    New NICE non-executive director appointment approved by the Secretary of State for Health and Social Care

  11. NICE recommends novel treatment for debilitating inherited skin condition

    Around 670 people in England with skin wounds caused by a rare inherited disorder to benefit from a new treatment to help the healing process.

  12. Artificial intelligence to speed up contouring in radiotherapy treatment planning

    Nine artificial intelligence technologies can be used to help plan the treatment of those undergoing external beam radiotherapy for cancers

  13. NICE launches first modular update to its methods and processes

    NICE’s methods and processes now include a proportionate approach to technology appraisals, and a new way of updating recommendations on COVID-19 treatments.

  14. Hundreds of thousands set to benefit from new treatment to prevent heart attacks and strokes

    NICE has published final draft guidance which recommends icosapent ethyl for reducing the risk of heart attacks and strokes in adults who have raised blood fats.

  15. More than 400 people could benefit from life-extending advanced lung cancer treatment

    Durvalumab recommended as an option for treating non-small-cell lung cancer.